top of page
    • Sep 10

Berlin based T-knife Therapeutics is carrying on the tradition of German leadership in TCR based technologies in oncology

CEO Thomas Soloway and CTO Elisa Kieback walk us through what makes T-knife unique in the construction and manufacturing of its cell therapies, and how they are readying to enter the clinic in PRAME.



Comentários

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE

bottom of page